American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: methodology and review of evidence.

Autor: Al-Haddad MA; Division of Gastroenterology., Elhanafi SE; Division of Gastroenterology, Texas Tech University Health Sciences Center, Paul Foster School of Medicine, El Paso, Texas, USA., Forbes N; Department of Medicine; Department of Community Health Sciences., Thosani NC; Center for Interventional Gastroenterology (iGUT), McGovern Medical School, UTHealth, Houston, Texas, USA., Draganov PV; Department of Gastroenterology., Othman MO; Baylor College of Medicine, Houston, Texas, USA., Ceppa EP; Division of Surgical Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Kaul V; Division of Gastroenterology and Hepatology, University of Rochester Medical Center, Rochester, New York, USA., Feely MM; Department of Pathology., Sahin I; Division of Hematology and Oncology, Section of Gastroenterology, University of Florida, Gainesville, Florida, USA., Ruan Y; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, Alberta, Canada., Sadeghirad B; Department of Health Research Methods, Evidence and Impact., Morgan RL; Department of Health Research Methods, Evidence and Impact; Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada; School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA., Buxbaum JL; Division of Gastrointestinal and Liver Diseases, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA., Calderwood AH; Section of Gastroenterology and Hepatology, Department of Medicine, Geisel School of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA., Chalhoub JM; Division of Gastroenterology and Hepatology, Department of Medicine, Staten Island University Hospital, Northwell Health, Staten Island, New York, USA., Coelho-Prabhu N; Department of Gastroenterology, Mayo Clinic, Rochester, Minnesota, USA., Desai M; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota, USA., Fujii-Lau LL; Gastroenterology Service, University of Hawaii, Honolulu, Hawaii, USA., Kohli DR; Pancreas and Liver Clinic, Providence Sacred Heart Medical Center, Spokane, Washington, USA., Kwon RS; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA., Machicado JD; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA., Marya NB; Division of Gastroenterology and Hepatology, University of Massachusetts Medical Center, Worcester, Massachusetts, USA., Pawa S; Department of Medicine, Section on Gastroenterology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA., Ruan W; Division of Pediatric Gastroenterology, Hepatology and Nutrition, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA., Sheth SG; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Storm AC; Department of Gastroenterology, Mayo Clinic, Rochester, Minnesota, USA., Thiruvengadam NR; Division of Gastroenterology and Hepatology, Loma Linda University, Loma Linda, California, USA., Qumseya BJ; Department of Gastroenterology.
Jazyk: angličtina
Zdroj: Gastrointestinal endoscopy [Gastrointest Endosc] 2023 Sep; Vol. 98 (3), pp. 285-305.e38. Date of Electronic Publication: 2023 Jul 25.
DOI: 10.1016/j.gie.2023.03.030
Abstrakt: This document from the American Society for Gastrointestinal Endoscopy (ASGE) provides a full description of the methodology used in the review of the evidence used to inform the final guidance outlined in the accompanying Summary and Recommendations document regarding the role of endoscopic submucosal dissection (ESD) in the management of early esophageal and gastric cancers. This guideline used the Grading of Recommendations, Assessment, Development and Evaluation framework and specifically addresses the role of ESD versus EMR and/or surgery, where applicable, for the management of early esophageal squamous cell carcinoma (ESCC), esophageal adenocarcinoma (EAC), and gastric adenocarcinoma (GAC) and their corresponding precursor lesions. For ESCC, the ASGE suggests ESD over EMR for patients with early-stage, well-differentiated, nonulcerated cancer >15 mm, whereas in patients with similar lesions ≤15 mm, the ASGE suggests either ESD or EMR. The ASGE suggests against surgery for such patients with ESCC, whenever possible. For EAC, the ASGE suggests ESD over EMR for patients with early-stage, well-differentiated, nonulcerated cancer >20 mm, whereas in patients with similar lesions measuring ≤20 mm, the ASGE suggests either ESD or EMR. For GAC, the ASGE suggests ESD over EMR for patients with early-stage, well or moderately differentiated, nonulcerated intestinal type cancer measuring 20 to 30 mm, whereas for patients with similar lesions <20 mm, the ASGE suggests either ESD or EMR. The ASGE suggests against surgery for patients with such lesions measuring ≤30 mm, whereas for lesions that are poorly differentiated, regardless of size, the ASGE suggests surgical evaluation over endosic approaches.
(Copyright © 2023 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE